214 related articles for article (PubMed ID: 7971997)
1. Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein.
Yeh CH; Shatkin AJ
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11002-6. PubMed ID: 7971997
[TBL] [Abstract][Full Text] [Related]
2. The Ser36-Ser37 pair in HeLa nuclear protein p21/SIIR mediates Ser/Thr phosphorylation and is essential for Rous sarcoma virus long terminal repeat repression.
Yeh CH; Zong WX; Shatkin AJ
J Biol Chem; 1995 Oct; 270(43):25313-5. PubMed ID: 7592688
[TBL] [Abstract][Full Text] [Related]
3. A cis-acting element in Rous sarcoma virus long terminal repeat required for promoter repression by HeLa nuclear protein p21.
Yeh CH; Shatkin AJ
J Biol Chem; 1995 Jun; 270(26):15815-20. PubMed ID: 7797584
[TBL] [Abstract][Full Text] [Related]
4. The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.
Mobley CM; Sealy L
J Virol; 2000 Jul; 74(14):6511-9. PubMed ID: 10864664
[TBL] [Abstract][Full Text] [Related]
5. Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity.
Mobley CM; Sealy L
J Virol; 1998 Aug; 72(8):6592-601. PubMed ID: 9658104
[TBL] [Abstract][Full Text] [Related]
6. Chicken YB-2, a Y-box protein, is a potent activator of Rous sarcoma virus long terminal repeat-driven transcription in avian fibroblasts.
Swamynathan SK; Nambiar A; Guntaka RV
J Virol; 1997 Apr; 71(4):2873-80. PubMed ID: 9060644
[TBL] [Abstract][Full Text] [Related]
7. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
[TBL] [Abstract][Full Text] [Related]
8. Transactivation of the Rous sarcoma virus long terminal repeat promoter by Marek's disease virus.
Tieber VL; Zalinskis LL; Silva RF; Finkelstein A; Coussens PM
Virology; 1990 Dec; 179(2):719-27. PubMed ID: 2173259
[TBL] [Abstract][Full Text] [Related]
9. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
Bowers WJ; Baglia LA; Ruddel A
J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers.
Ryden TA; de Mars M; Beemon K
J Virol; 1993 May; 67(5):2862-70. PubMed ID: 8386280
[TBL] [Abstract][Full Text] [Related]
11. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.
Gorman CM; Merlino GT; Willingham MC; Pastan I; Howard BH
Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6777-81. PubMed ID: 6294651
[TBL] [Abstract][Full Text] [Related]
12. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
Boulden A; Sealy L
Virology; 1990 Jan; 174(1):204-16. PubMed ID: 2152992
[TBL] [Abstract][Full Text] [Related]
13. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
Banders UT; Coussens PM
Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the rous sarcoma virus long terminal repeat-driven transcription by in vitro methylation: different sensitivity in permissive chicken cells versus mammalian cells.
Hejnar J; Plachý J; Geryk J; Machon O; Trejbalová K; Guntaka RV; Svoboda J
Virology; 1999 Mar; 255(1):171-81. PubMed ID: 10049832
[TBL] [Abstract][Full Text] [Related]
15. Cloning of Rous sarcoma virus enhancer factor genes. I. Evidence that RSV-EF-I is related to Y-box (inverted CCAAT) binding proteins and binds to multiple motifs in the RSV enhancer.
Kandala JC; Guntaka RV
Virology; 1994 Feb; 198(2):514-23. PubMed ID: 8291233
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing physiological variations in the activity of the Rous sarcoma virus long terminal repeat.
Lang A; Fincham VJ; Wyke JA
Virology; 1993 Oct; 196(2):564-75. PubMed ID: 8396803
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro.
Greuel BT; Sealy L; Majors JE
Virology; 1990 Jul; 177(1):33-43. PubMed ID: 2162108
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
19. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.
Houtz EK; Conklin KF
J Virol; 1996 Jan; 70(1):393-401. PubMed ID: 8523553
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences.
Vacca A; Martinotti S; Screpanti I; Maroder M; Felli MP; Farina AR; Gismondi A; Santoni A; Frati L; Gulino A
J Biol Chem; 1990 May; 265(14):8075-80. PubMed ID: 2159467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
